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Does mammographic screening and a negative
result aVect attitudes towards future breast
screening?
C H C Drossaert, H Boer, E R Seydel
Abstract
Objectives—To investigate the impact of
an experience of a benign mammographic
result on intention to seek medical help
immediately in the case of breast abnor-
malities, and on intentions and thoughts
about future participation in screening.
Setting—The Dutch Breast Cancer
Screening Programme for women aged
50–69.
Methods—Subjects were women who were
invited for an initial breast examination:
223 women filled out a questionnaire
about 10 days before and about 6 weeks
after their initial breast examination. To
be able to control for possible test eVects,
another group of 293 women filled out a
questionnaire only after mammography.
Changes in thoughts and intentions were
examined.
Results—Most women were very satisfied
with the course of their initial breast
examination, although pain or discomfort
was often mentioned. No clues to suggest
false reassurance were found: more than
99% of the women would consider the pos-
sibility of breast cancer if they felt a lump
in one of their breasts. In such a situation,
most women intended to seek medical
help within a week. These variables were
not influenced by the experience of mam-
mography with a benign result. In general,
women were very positive about (repeat)
participation, both before and after
screening. After screening, the average
woman perceived fewer costs in partici-
pating, and perceived her own ability to
engage in future screening as higher.
However, the experience of pain and anxi-
ety during the initial screening did lead to
reverse eVects. Women who were less sat-
isfied about their treatment by the staV
were more likely to change their inten-
tions to reparticipate in a negative way.
Conclusions—As, in general, women be-
came more positive about regular partici-
pation after they had attended breast
cancer screening, eVorts to improve first
round attendance must be continued. At
the same time, the screening organisa-
tions must continue to prioritise the high
level of client friendliness throughout the
screening. No evidence for detrimental
eVects of screening through false reassur-
ance among participants was found.
(J Med Screen 2001;8:204–212)
Keywords: breast cancer; screening; experiences; be-
liefs; participation
Based on the promising results of experimental
studies with population screening for breast
cancer in the United States,1 Sweden,2 3 and
The Netherlands4 5 a nationwide breast cancer
screening programme has been gradually
implemented in The Netherlands since the
early 1990s. In the Dutch screening pro-
gramme, all women aged 50 to 69 are invited
for a free mammography every 2 years. Most
women participating in this screening pro-
gramme receive a negative screening result—
that is, they learn every 2 years that no abnor-
malities were found. In this study we examined
the interpretation by the women of a negative
screening result, and to what extent breast
screening with a normal result aVected wom-
en’s intentions towards (a) seeking medical
help promptly in the case of breast abnormali-
ties and (b) repeat participation in subsequent
screening rounds.
IMPACT OF SCREENING ON INTENTION TO SEEK
HELP IN THE CASE OF FUTURE BREAST
ABNORMALITIES
It has been suggested by various authors6–8 that
screening might cause false reassurance among
those women who participate in the pro-
gramme and receive negative screening results.
False reassurance describes the feelings of
security associated with receiving a negative
breast screening result: women might think
(mistakenly) that they are “protected” against
getting breast cancer, which might lead to a
more casual attitude in those particular women
to remaining alert to the warning signs of
breast cancer. False reassurance can be detri-
mental, because it might cause delay in
diagnosis and treatment of tumours that
develop in the period between two screening
rounds. Such so called “interval tumours”
—breast cancers diagnosed between two
screening rounds—are common in population
based breast screening. It is expected that the
ratio between screen detected tumours and
interval tumours is about 2–3:1 for women
older than 50 years.2 9 10 Because of the high
incidence of interval tumours, it is important
that women who participate in regular breast
screening remain alert to the symptoms of
breast cancer, and that they seek medical
attention immediately for any suspicious find-
ings. It is important that women understand
the relative nature of the screening result, and
that breast cancer might occur despite the
negative result. To our knowledge, a woman’s
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interpretation of a negative breast screening
result, and the impact of screening on intention
to seek help, have not been investigated. In this
study we examined whether a negative screen-
ing result was well interpreted and whether
false reassurance occurred.
IMPACT OF A NEGATIVE SCREENING RESULT ON
THOUGHTS AND ATTITUDES ABOUT FUTURE
PARTICIPATION
Among other factors, participation is an
important determinant for the success of the
breast screening programme. In this respect, it
is important that women not only attend the
initial screening, but also all subsequent
screening rounds. Various studies have shown
that participation rates, although high in the
first round, often drop during the course of the
screening programme.11–13 Although relatively
little research has been undertaken to establish
factors that improve or inhibit long term
participation in breast screening
programmes,14–20 several studies have investi-
gated factors that improve or impede first
round participation in such programmes.21–23
Alongside sociodemographic factors such as
age, marital status, and educational back-
ground, the attitudes and opinions underlying
a woman’s decision to participate in screening
have been studied. Insight into these so called
“cognitive determinants” is important as it
provides a useful basis for health promotion
activities.
Various psychological models—such as the
health belief model,24 the theory of planned
behaviour,25 26 and protection motivation
theory27 28—provide various cognitive determi-
nants underlying the decision to engage in
health behaviour. These theories, or combina-
tions of them, have been used to examine
numerous health behaviours including non-
participation in breast cancer screening.15 16 29–33
One major determinant is the perceived
threat of the disease, including beliefs about
susceptibility and severity—for example, a
women is more likely to participate in breast
cancer screening if she considers herself more
susceptible to breast cancer and perceives
breast cancer as a more severe disease. Another
cognitive determinant of participation is the
balance between costs and benefits of partici-
pation. A woman is more likely to participate in
breast cancer screening if she associates fewer
costs (radiation, worries, and pain) and more
benefits (reassurance, early detection) from it.
Subjective norm refers to a woman’s percep-
tion of expectations of other relevant people
about her participation in breast screening and
is another factor that might influence a
woman’s decision to participate in screening. A
final cognitive determinant of participation in
screening is self eYcacy, defined as a woman’s
belief in her ability to actually participate in
breast screening.
In our study, these cognitive determinants
were measured both before and after screening
to gain insight into the eVects of a screening
experience with a negative result. We expected
that the cognitive determinants of repeat
participation would be influenced by the expe-
rience itself and by a negative screening result.
For instance, a negative screening result might
influence a woman’s ideas about her suscepti-
bility to breast cancer. Moreover, the actual
experience of undergoing a mammography
(which is inseparably connected to the screen-
ing result) is also likely to influence a woman’s
ideas about her reparticipation in future
rounds. For instance, negative experiences
during the mammography (anxiety or pain)
might result in lower expectations of self
eYcacy. Both diminished expectations of self
eYcacy and diminished susceptibility might
eventually reduce the intention to reparticipate
in future screening rounds.
In summary, our study was conducted to
examine the eVect of a screening experience
with a negative result on women’s beliefs and
intentions toward future participation in the
screening programme, and on women’s inten-
tions to seek help in the case of breast
abnormalities.
Subjects and methods
SETTING
Our study took place in a rural area in the east
of The Netherlands, where the first round of
the Dutch national screening programme was
performed. The breast examinations were per-
formed in semimobile screening units. Names
and addresses of all women aged 50 to 69 were
provided by the population registers of the
local councils. A regional screening organisa-
tion invited every woman by letter for a free
mammogram, giving a fixed appointment
which could be changed on request. An infor-
mation leaflet was enclosed with the invitation,
giving general information about breast can-
cer, the benefits of early detection and about
the breast screening programme, and more
detailed information about the specific proce-
dures of the breast examination. Every woman
received the outcome of the screening by post
within 2 weeks of the mammogram.
DESIGN AND SUBJECTS
During a 3 month period in which women
were invited for their initial mammogram, 20%
were selected at random to participate in the
study. To measure the eVects of the screening,
two measurements were taken: about 10 days
before the scheduled mammography and
about 6 weeks after it. Written questionnaires
were used both before and after mammogra-
phy. To ensure that the questionnaire was actu-
ally filled out before the mammogram, the
questionnaires before mammography were col-
lected at the women’s homes.
Because women were asked to fill out two
similar questionnaires in a short period, the
danger of a testing eVect existed. To control for
possible testing eVects, no questionnaire before
mammography was sent to part of the sample
(the after only group). Women were randomly
assigned to either the before+after group or to
the after only group. The response data are
presented in table 1. In the before+after group,
247 women (55%) completed both question-
naires; in the after only group 327 women
(75%) completed the questionnaire. Women
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who were under treatment for breast cancer
(before+after group n=6: after only group
n=12) were excluded from analyses. Because
the study was aimed at examining the eVect of
participating in screening with a negative
(benign) result, women who had not partici-
pated in the initial screening (before+after
group n=11: after only group n=20) and
women who had received a positive (suspect)
screening result (before+after group n=1: after
only group n=2) were also excluded from
further analysis. This left a total of 522 subjects
for analysis (before+after group n=229: after
only group n=293).
QUESTIONNAIRES
The questionnaires contained questions on the
following subjects:
Personal characteristics and use of information
leaflet
Personal characteristics and use of the health
education leaflet were measured only once;
before mammography in the before+after
group, and after screening in the after only
group. Demographic characteristics included:
age, education, employment, and marital
status. Each woman was asked about her
experiences with breast cancer: if she had ever
had a benign breast abnormality; and whether
she knew someone close to her who had been
treated for breast cancer. To establish family
history of breast cancer, women were asked to
indicate whether their mother or sister had
ever been treated for breast cancer. Use of the
information leaflet was measured by asking
women the extent to which they had read the
enclosed information leaflet (not at all,
glanced at it, read some parts, read it
completely).
Cognitive determinants of repeat participation
Intention to reparticipate was measured for
the next screening round and all subsequent
screening rounds. Answering options varied
from “strongly intend to participate” (2) to
”strongly intend not to participate” (-2).
Because the items were highly intercorrelated
(r=0.80) mean scores were computed. Ben-
efits of participation in breast screening were
measured with a three item scale (á=0.67). An
example is: “If I would participate in the
screening and abnormalities were found, the
possibility of breast conserving treatment
would be higher.....fully disagree (1) to fully
agree (5)”. Costs (women’s perceptions of
physical and psychological costs of participat-
ing in breast screening) were measured with a
four item scale (á=0.60). For example: “Hav-
ing a mammogram, takes a lot of time”... fully
disagree (1) to fully agree (5)’. Susceptibility
was measured with a four item scale (á=0.77).
An example of a susceptibility item is: “The
chance that I will develop breast cancer in my
lifetime is... very small (1) to very high (5)”.
Subjective norms were measured based on the
work of Ajzen and Fishbein25 and were
composed of two parts: normative beliefs and
motivations to comply. An example of a
normative belief question is: “My (referent
person) thinks that I certainly . . . should (2) to
should not (-2) participate”. An example of a
motivation to comply question is: “When it
comes to early detection behaviour I . . . do
strongly (3) to do not (0) . . . comply with the
opinion of my (referent person)”. Normative
beliefs and motivations to comply were meas-
ured relative to six referents—namely: partner,
children, family/friends, peers, family doctor,
and the organisation sending the mammogra-
phy invitations. The subjective norm was
computed by taking the mean of the products
of normative beliefs and motivation to comply
(á=0.79). Self eYcacy was measured with
seven items about the diYculties that women
expected with several practical and psycho-
logical aspects of screening participation
(á=0.71). For example: “Getting to the
screening unit is very diYcult (1) to not diY-
cult at all (4)”. All the above mentioned
cognitive determinants were measured in the
questionnaire both before and after mammog-
raphy.
Satisfaction and experiences with mammography
The questionnaire after screening included
some questions about women’s experiences
during the mammography. General satisfaction
was measured with two questions: firstly,
women were asked to indicate how satisfied
they were in general with the course of the
breast examination (ranging from very unsatis-
fied (1) to very satisfied (4)) and secondly,
women were asked to what extent had the
breast examination been as they expectated
(ranging from worse than expected (-2) to bet-
ter than expected (2)).
A few questions dealt with women’s appre-
ciation of the organisational aspects of the
screening experience—namely: travel times,
waiting times, and appreciation of privacy
within the unit. Perceived treatment by staV
was measured with an eight item scale
(á=0.80). Women were asked to mark at four
point scales the extent to which they found the
radiology assistants kind, comforting, inter-
ested, hurried, and impersonal, and whether
the staV were skilled, whether they took
enough time, and whether they provided
enough information. Anxiety provoked by the
mammography was measured relative to three
periods: before the examination, during the
examination, and in the period between the
examination and the result of the mammo-
gram. For each period, women were asked to
mark on a four point scale the extent to which
they felt tense and anxious. Also, women were
asked to mark how much they had worried
about the test results. As the seven questions
were highly intercorrelated, the items were
summarised into one mammography provoked
anxiety scale (á=0.94). Pain was measured by
Table 1 Response to questionnaires before and after mammography
Group
Before After
Sent Returned % Sent Returned %
Before+after 451 321 71 321 247 77
After only — — — 435 327 75
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asking women to indicate the amount of expe-
rienced pain on a four point scale, ranging
from not painful (1) to very painful (4).
Knowledge about interpretation of the screening
result and intention to seek help
Both knowledge and intention to seek help
were measured twice, before and after mam-
mography. Knowledge about the interpretation
of the screening result was measured with three
true or false statements. These statements
were: “If an abnormality is found on the mam-
mogram, this always means that you have
breast cancer”, “If you participate in the
screening programme, you cannot get breast
cancer anymore”, and “Participation in the
screening programme makes breast self exami-
nation no longer necessary”. To measure
intention to seek help, the following scenario
was presented to the women: “Imagine, 2
months from now, that you are taking a shower.
While washing yourself you suddenly discover
a small, painless lump in your left breast . . ..
The scenario was followed by two questions.
Women were asked to indicate on a five point
scale, ranging from certainly not (-2) to
certainly (2), the extent to which they may
think the lump could be breast cancer. They
were also asked how long they would wait
before contacting their general practitioner
(GP) with the symptom. Answering options
varied from “would contact GP within one
week” (1) to “would wait longer than 6
months” (6).
STATISTICAL ANALYSIS
All analyses were performed with SPSS-PC+.
All tests were two tailed and ás were set on
0.05. The eVects of screening and screening
result on intention to seek help and on
determinants of repeat participation were
examined by comparing scores after with
before mammography, by multivariate and
univariate analyses of variance (ANOVA).
Before this, we checked whether the scores
after screening of the before+after group
diVered significantly from the scores after
mammography of the after only group, to
examine whether testing had had an eVect.
Where no significant eVects of testing were
established, diVerences within subjects
between before and after mammography in the
before+after group were examined. Where
significant testing eVects appeared, the scores
of the after only group were compared with
the scores before mammography of the
before+after group (between subjects design).
Results
DESCRIPTIVE RESULTS
Personal background variables, experiences with
breast cancer, and use of health education
Table 2 shows that most of the women in the
study were married, unemployed, and less well
educated. Most women knew someone in their
social environment who had been treated for
breast cancer. About 11% reported to have a
family history of breast cancer (mother or
sister). Only 54% of the respondents indicated
that they had read the enclosed information
leaflet completely. Table 2 shows that no
significant diVerences were found between the
before+after group and the after only group,
indicating that the randomisation had been
successful.
Satisfaction and experiences with the first
mammography
In general, women were satisfied with their first
breast examination: 85% indicated that they
were very satisfied; 13% that they were rather
satisfied; only 5% considered the examination
to be worse than expected; nearly 75% consid-
ered it to be better than expected. Using open
ended questions, women were asked what
turned out to be better or worse than expected.
Many women wrote nothing, everything, or the
examination. The more concrete answers are
summarised in table 3. One remarkable finding
was that pain was the most frequent answer on
both questions. Obviously, many women had
expected the examination to be painful.
Another notable finding was that some women
indicated that the pain had lasted (for a long
time) after the breast examination.
Table 4 summarises the answers to the ques-
tions on diVerent aspects of the mammogra-
phy. The figures from table 4 underline the
above finding that, in general, women were sat-
isfied with the initial screening round. The
screening unit oVered enough privacy and was
placed within easy reach of nearly all women.
The waiting times were acceptable. Women
were very positive about the treatment by the
radiology assistants and for most women the
Table 2 Personal characteristics, experiences with breast
cancer, and use of information leaflet (n=522)
Age (mean) 59.0
Marital state (%):
Married 84
Single, divorced, or widowed 16
Employment (%):
Unemployed 85
Part time job 12
Full time job 3
Education (%):
low 74
Medium 21
High 5
Family history of breast cancer (%):
Yes 11
Ever had a (benign) breast abnormality (%):
Yes 12
Breast cancer in someone close (%):
Yes 62
Has read leaflet completely (%):
Yes 54
Table 3 Aspects of screening experience turning out to be
better or worse than expected
n (%)
Better than expected:
Pain 33 (41)
Treatment by staV, and atmosphere 30 (38)
Rapid 13 (16)
Screening result 4 (5)
Total 80 (100)
Worse than expected:
Pain, or duration of pain 19 (73)
Long waiting time 2 (8)
Extra mammography necessary 2 (8)
Laboratory assistant did not talk 1 (4)
Long distance to unit 1 (4)
There was no physical examination 1 (4)
Total 26 (100)
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screening experience had not caused too much
anxiety. However, 40 women (8%) had anxiety
scores of 2.5 or higher, which indicate moder-
ate to high levels of anxiety. Over half of the
respondents (61%) considered the mammo-
gram to be at least a little painful. Considerable
to severe pain was mentioned by 14% of
respondents. There were no significant diVer-
ences in the experiences of the initial mam-
mography between the before+after group and
the after only group, indicating that the
baseline measurement had not influenced the
breast screening experience.
Knowledge about interpretation of the screening
result
The answers on knowledge about interpreta-
tion of the result before and after screening are
presented in table 5 and indicate that knowl-
edge was very high. ÷2 Tests showed that there
were no significant diVerences between the
answers after screening of the before+after and
after only groups. Nor were there any signifi-
cant diVerences between the scores before and
after mammography. This indicates that the
screening experience had not aVected women’s
knowledge about the interpretation of the
result.
EFFECTS OF THE EXPERIENCE OF MAMMOGRAPHY
WITH NORMAL BENIGN RESULTS
EVects on intention to seek help in the case of
breast abnormalities
The mean scores on the two items on intention
to seek help are presented in table 6. The table
shows that most women would seriously
consider the possibility of breast cancer if they
discovered a breast lump in the near future.
Both before and after the screening, less than
1% of the women indicated that a breast lump
would definitely not be breast cancer. Most
women (>75%) would visit their GP within
less than 1 week. Less than 4% would wait
more than 1 month, less than 1% would wait
longer than 2 months. The screening experi-
ence with a favourable result did not have any
eVects on these findings: even when women
were recently reassured by a negative mammo-
gram, they intended to seek medical help
immediately if they discovered a breast lump in
the near future.
EVects on cognitive determinants towards repeat
participation
From the mean scores in table 7, it can be con-
cluded that women in general were very
positive about repeat participation: both before
and after the first breast examination, women
strongly intended to reparticipate in future
screening rounds. In general, women felt
susceptible to breast cancer, connected more
benefits than costs to participating in the breast
screening programme, were encouraged by
their social environment to participate in the
screening programme, and did not consider
participation to be too diYcult.
A significant overall eVect of screening was
established in the cognitive determinants of
repeat participation (Fmultiv(7,469)=3.5,
p<0.001). Inspection of univariate tests
showed that the overall diVerence was mainly
caused by subjective norms. Women who had
filled out a questionnaire before screening felt
more strongly encouraged by their social envi-
ronment in the questionnaire after screening
than women who had not filled out the first
questionnaire. The screening experience lead
to a significant change in ideas about costs and
self eYcacy: after the first breast examination
women linked fewer costs to undergoing a
breast examination and considered future par-
ticipation in the breast screening programme
to be less diYcult.
Table 4 Evaluation of diVerent aspects of the first
mammography (n=522)
Required time to get to the unit (min, %):
<15 71
15–30 24
30–60 5
>60 —
Means of transport (%):
On foot 3
By bicycle 61
By car 34
By public transport or taxi 3
Waiting time (min, %):
No waiting time 13
<15 78
15–30 8
>30 1
Privacy within unit (%):
Too little privacy 1
Little privacy 2
Enough privacy 97
Pain (%):
Not painful 39
A little painful 47
Rather painful 11
Very painful 3
Treatment by staV:
Eight item scale (min=1, max=4) 3.6
Anxiety caused by mammography:
Seven item scale (min=1, max=4) 1.6
Table 5 Knowledge (%) about interpretation of the screening result
Before screening (n=224) After screening (n=522)
Incorrect
answer
Correct
answer*
Did not
know
Incorrect
answer
Correct
answer*
Did not
know
If an abnormality is found on the mammogram,
this always means that you have breast cancer
4 81 15 4 78 19
Participation in the screening programme makes
breast self examination no longer necessary
3 89 8 3 94 3
If you participate in the screening programme, you
cannot get breast cancer anymore
1 92 7 1 94 5
*Answering options were true, false, and don’t know. For all three statements the correct answer was false.
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Influence of specific experiences on determinants
of repeat participation
From the previous results it can be concluded
that before, as well as after, the first breast
screening experience, women were on average
very positive about reparticipation. Moreover
it was found that, although most women were
very positive about the course of their initial
breast examination, a few reported explicitly
negative experiences such as pain or anxiety
during the screening. The correlation coeY-
cients between the specific experiences during
initial mammography and the cognitive deter-
minants of repeat participation, measured in
the two questionnaires are presented in table
8.
It can be read from table 8 that most experi-
ences during the first mammography were only
weakly correlated with cognitive determinants
of repeat participation expressed in the second
questionnaire. Women’s intention to repartici-
pate in future screening was significantly
stronger as they thought they had been better
treated by the staV, and experienced less pain
during the initial breast examination. Experi-
enced pain and anxiety were moderately corre-
lated with perceived costs and to expectations
of self eYcacy. A notable finding from table 8 is
that some experiences of mammograms were
significantly correlated with the cognitive
determinants expressed before the screening.
To examine the impact of experiences on
intention to reparticipate, a partial correlation
analysis was performed. In this analysis, the
correlation was examined between intention as
indicated in the second questionnaire and spe-
cific experiences, while including intention as
indicated in the first questionnaire as a covari-
ate. The results showed that treatment by staV
was the only experience with an impact on
intention after screening (rpart=0.19, n=217,
p<0.001). Similar analyses for the other cogni-
tive determinants (except subjective norms)
were performed. Results showed that pain dur-
ing mammography had a significant influence
on both self eYcacy (rpart=−0.19, n=219,
p=0.004) and on beliefs about the costs of
screening (rpart=0.40, n=216, p=0.004). Like-
wise, anxiety provoked by the mammography
was correlated to self eYcacy (rpart=−0.27,
n=219, p<0.001) and costs (rpart=0.33, n=216,
p<0.001). All other (partial) correlations be-
tween experiences and cognitive determinants
were not significant.
An additional multiple regression analysis, in
which the cognitive determinants from table 8
(benefits, costs, susceptibility, severity, and self
eYcacy) were included to predict intention,
showed that the cognitive determinants meas-
ured after screening significantly predicted the
intention to reattend after screening (R=0.41,
F(6,479)=18.9, p<0.001). Expectations of self
eYcacy (â=0.42, p<0.001) and perceived sus-
ceptibility (â=0.12, p=0.005) were independ-
ent predictors of intention to reattend.
Table 6 EVects of favourable screening result on intentions to seek help in the case of breast abnormalities
Imagine somewhere in the near future you
discover a small painless lump in your breast
Mean scores of questionnaire Test for eVect
Before
mammography
(before+after
group)
After
mammography
(before+after
group)
After
mammography
(after only
group)
EVect of
testing*
EVect of
screening†
Would you think this may be cancer?
(−2=definitely not . . . 2=definitely)
0.5 0.6 0.7 NS NS
How long (weeks) would you wait before
contacting your GP? (1=<1 week . . .
6=>6 months)
1.3 1.2 1.3 NS NS
F(2,449)=0.7 F(2,174)=1.0
NS NS
*MANOVA (between subjects design) was used to compare the scores after mammography of the before+after group and the after
only group.
†MANOVA (within subjects design for repeated measures) was used to compare the scores after mammography with the scores
before mammography of the before+after group.
Table 7 Mean scores on cognitive determinants of repeat participation measured before the first and after the second
questionnaire in the initial round of the breast cancer screening programme
Mean scores Test for eVect
Before
mammography
(before+after
group)
After
mammography
(before+after
group)
After
mammography
(after only
group)
EVect of
testing *
EVect of
screening
(between
subjects)†
EVect of
screening
(within
subjects)‡
Intention (-2/2) 1.8 1.8 1.8 NS NS NS
Benefits (1/5) 4.3 4.3 4.3 NS NS NS
Costs (1/5) 2.1 1.9 1.9 NS .01 0.001
Susceptibility (1/4) 2.9 2.9 2.8 NS NS NS
Severity (1/4) 3.7 3.6 3.6 NS NS NS
Subjective norms (-6/6) 2.9 3.2 2.7 0.001 NS 0.010
Self eYcacy (1/4) 3.8 3.9 3.9 NS 0.00 0.003
F(7,469)=3.5 F(7,461)=2.7 F(7,188)=5.7
p=0.001 p=0.010 p<0.001
*MANOVA (between subjects design) was used to compare the scores after mammography of the before+after group with the after
only group.
†MANOVA (between subjects design) was used to compare the scores after mammography of the after only group with the scores
before mammography of the before+after group.
‡MANOVA (within subjects design for repeated measures) was used to compare the scores after mammography with the scores
before mammography of the before+after group.
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Discussion
The results of the study showed that women
were generally very positive about their first
breast examination. The screening unit was
within easy reach for nearly everyone, women
did not have to wait long for their turn, the
(semimobile) screening unit oVered enough
privacy, and women tended to be satisfied
about their treatment by the staV. For most
women, the breast examination and waiting for
the test results did not cause extreme anxiety.
However, pain or discomfort was mentioned
by many participants: for most women (47%)
the breast examination had been a little
painful, 14% reported moderate to severe pain.
These findings are consistent with various
other studies which show generally high levels
of satisfaction with screening (including re-
spect for privacy and treatment by staV) but in
which pain or discomfort is often
mentioned.34–38
Various authors have suggested that screen-
ing might cause false reassurance.6–8 The
results of our study provide no indications of
false reassurance among women who received
a negative screening result. Nearly all women
knew that participating in the breast cancer
screening programme does not mean that you
cannot get breast cancer in the future.
Likewise, nearly all women knew that having a
mammogram does not make breast self exami-
nation superfluous. More than 99% of the
women would consider the possibility of breast
cancer if they discovered a lump in one of their
breasts. If this occurred, most women intended
to seek medical help within a week. Less than
4% would wait more than 1 month, less than
1% would wait longer than 2 months. These
variables were not influenced by the experience
of mammography with a benign result. Even
when a woman was recently reassured by a
negative mammogram, she realised that a lump
might mean breast cancer and would seek
medical help promptly. However, the results
must be interpreted with some caution as the
assessed intentions to seek help referred to a
hypothetical situation and might not corre-
spond with actual behaviour. In a retrospective
study by Boer and Seydel,39 it was found that
13% of patients with recently diagnosed breast
cancer reported having postponed consulting a
doctor for as long as possible (at least for more
than several weeks after discovering the symp-
toms). The results from our study are much
more optimistic: it can therefore be questioned
whether the expressed intentions would corre-
spond with actual behaviour. However, this
study was primarily focused on detecting
changes in opinions as a result of an experience
of mammography. The results show that no
such changes occurred after a negative mam-
mography result. A second point to be made is
that the women in the study had experienced
only one screening examination. It is possible
that if a woman were to receive many negative
screening results, she would be falsely reas-
sured in the long run. To examine this, a longi-
tudinal design would be necessary.
One of the study’s main aims was to examine
the influence of an experience of mammogra-
phy with normal, benign results on women’s
intentions to repeat participation. The results
showed that in general women were very posi-
tive about repeat participation, both before and
after screening. After screening, the average
woman connected even fewer costs with
participating (in particular the costs: makes me
worry and takes a lot of time were less often
mentioned after screening), and perceived her
own ability to engage in future screening as
higher. The observed changes might reflect an
eVect of the negative screening result or an
eVect of the actual experience of undergoing a
mammography. The study design does not
allow for conclusions to be drawn about the
exact cause of the changes (the two factors
cannot be separated). However, it is likely that
the observed changes in perceived costs and
self eYcacy are caused by the experience of
mammography, which was better than ex-
pected for most women. We thought that a
negative screening result might influence a
woman’s ideas about her susceptibility to
breast cancer. The results showed that no
significant diVerences on susceptibility were
found before and after screening. The inten-
tion to participate in subsequent screening
rounds was very high at both measurements
Table 8 Correlations between experiences during first mammography† and cognitive determinants of repeat participation,
expressed after and before mammography
Travelling time Waiting time Treatment by staV Pain Anxiety
Cognitive determinants expressed after the mammography:
Intention (−2/2)‡ — −0.13* 0.22*** −0.15*** —
Benefits (1/5)‡ — — — — 0.12*
Costs (1/5)‡ 0.13** — — 0.43*** 0.53***
Susceptibility (1/4)‡ −0.11* — — — 0.16**
Severity (1/4)‡ — — 0.13* — 0.14**
Subjective norms (−6/6)§ — — — — 0.22**
Self eYcacy (1/4)‡ −0.11** — 0.11* −0.29** −0.52**
Cognitive determinants expressed before the mammography:
Intention (−2/2) −0.16* — — — —
Benefits (1/5) — −0.15* −0.16* — 0.12*
Costs (1/5) 0.19* — — 0.14* 0.41***
Susceptibility (1/4) −0.11* — — — 0.16*
Severity (1/4) — — −0.18** — 0.17**
Subjective norms (−6/6) — — — — 0.19**
Self eYcacy (1/4) −0.15** — — — −0.48**
*p<0.05; **p<0.01; ***p<0.001.
†Privacy within the screening unit was not included because of its distribution (nearly all women (97%) considered the privacy suf-
ficient).
‡n=523, data after mammography from both the before+after group and after only group were included.
§n=294, data after mammography from the before+after group were excluded, because of the eVect of testing.
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and was not aVected by the initial screening
experience. These results, especially the find-
ing that participation in screening improved
self eYcacy and reduced considerations about
the costs, suggest that eVorts to improve first
round participation should be continued.
In this study the eVect of specific experi-
ences, such as the duration of the travel times,
the amount of pain and anxiety, and the degree
of satisfaction about treatment by staV, on cog-
nitive determinants, was also examined. One
interesting finding was that some experiences
(expressed after mammography) were signifi-
cantly correlated with cognitive determinants
expressed before the screening. This indicates
that the screening experience is determined by
previous expectations. Women who before-
hand anticipated more costs to participating
and less ability to participate, did indeed expe-
rience more distress and more pain during
their initial breast examination. Women who
(before screening) connected more benefits to
the screening, reported (after screening)
shorter waiting times and were more satisfied
with the treatment by staV. This indicates that
a positive attitude towards screening can aVect
the perception of what is actually happening
during the initial breast examination. On the
other hand, some negative experiences did
result in less positive views about reparticipa-
tion. As women experienced more pain or
more anxiety during the breast examination,
their expectations of self eYcacy decreased and
they were more likely to change their beliefs
about the costs associated with screening (but
not their intentions to reparticipate in future
screening rounds). A significant finding was
that women who were less satisfied about treat-
ment by staV were more likely to change their
reparticipation intentions negatively. It is im-
portant to note that in the present study no
actual repeat participation was measured.
Future research has yet to show whether wom-
en’s positive intentions were indeed trans-
formed into repeat participations.
Finally it should be noticed that our study
was carried out in a rural area. Previous
research has shown that in organised breast
screening, attendance rates tend to be higher in
rural areas than in urban areas.23 40 This means
that the results of this study may not be gener-
alisable to the whole population.
PRACTICAL IMPLICATIONS
The results from this study suggest that eVorts
to improve first round participation must be
continued, as in general women who can be
convinced to participate once will become
more positive about regular participation. The
screening experience with negative results
helps women to connect fewer costs with
screening and makes them more comfortable
about their own abilities to participate. Along-
side this, the screening organisations must
continue to prioritise maintaining a high level
of client friendliness during the screening. Our
study showed that most women strongly
intended to reparticipate in future screening
rounds, even if they reported negative experi-
ences like pain or anxiety. For some women,
however, negative experiences did influence
thoughts about future participation. Women
who were less satisfied about the way they were
treated by staV changed their intentions to
reparticipate in a negative way. Finally, the
results of our study show that most women
seem to be very aware of how to interpret a
negative screening result. Nearly all women
realised that the negative screening result is not
an absolute protection against breast cancer,
and most women did not change their
intentions about consulting a GP immediately
in the case of symptoms of breast cancer. This
indicates that additional health education
alongside a negative screening result does not
seem necessary at the present time.
This study was financed by the Dutch Cancer Society.
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